Rockville, Maryland — October 7, 2026 — The global powder-filled hard gelatin capsules market is valued at USD 5.9 billion in 2026 and is projected to reach USD 10.1 billion by 2036, expanding at a 5.5% CAGR during the forecast period. The market is expected to create an absolute dollar opportunity of USD 4.2 billion through 2036 as pharmaceutical formulators, nutraceutical manufacturers, and capsule suppliers continue to rely on established hard-shell formats for powder-based oral dosage products.
Get detailed market forecasts, competitive benchmarking, and pricing trends:
Demand is being supported by the continued use of prescription oral solid-dose medicines, where accurate powder filling, predictable disintegration, and consistent capsule-shell performance remain important to formulation and manufacturing operations. Fact.MR identifies prescription oral solid-dose use as the strongest growth driver, with an estimated +1.4% impact on CAGR. Immediate-release formulation familiarity also contributes to market expansion, while nutraceutical brands increasingly use hard capsules for powders requiring portion control, taste masking, and convenient consumer handling.
Type A Gelatine Capsules represent the leading product segment, accounting for 68.70% of the market in 2026. Their dominance reflects the familiarity of pork-skin gelatine as a shell-forming material for powder-filled capsule applications. By capsule size, 000 Capsule Size is expected to hold 56.40% share in 2026, supported by its larger internal capacity for formulations requiring higher powder fill volumes. Immediate Release Capsules lead the dosage-system segment with a 39.50% share, while Antibacterial Drugs account for 45.20% of application demand. The pharmaceutical industry represents 21.00% of the end-use market in 2026, supported by validated capsule-filling infrastructure and regulated oral solid-dose portfolios.
The United States is projected to register the fastest growth among the countries highlighted in the report, advancing at a 6.1% CAGR through 2036. Prescription-drug demand, domestic capsule supply expansion, and ongoing pharmaceutical development are supporting the country’s outlook. Germany follows with a 5.7% CAGR, underpinned by substantial pharmaceutical expenditure and stringent quality expectations across regulated manufacturing. France is expected to expand at a 5.2% CAGR, with reimbursed pharmacy volumes and widespread use of routine oral medicines supporting demand for capsule-based formulations. Fact.MR also reports country-level growth of 4.6% for Italy and 4.1% for Spain, reflecting continued pharmaceutical spending, prescription financing, and clinical-research activity.
The competitive landscape includes major hard-capsule suppliers such as ACG Worldwide, Qualicaps, Suheung Co. Ltd., and CapsCanada Corporation. These companies compete around shell consistency, documentation, filling-machine compatibility, pharmaceutical-grade production, and supply reliability. Other suppliers identified by Fact.MR include Qingdao Yiqing Medicinal Capsules Co. Ltd., Shanxi Guangsheng Medicinal Capsules Co. Ltd., Healthcaps India Ltd., Roxlor, Sunil Healthcare Ltd., and Natural Capsules Ltd., broadening competition across regional pharmaceutical and nutraceutical supply chains.
Manufacturers are also responding to evolving sourcing and formulation requirements. Fact.MR highlights regional capsule supply expansion and filling-equipment upgrades as important opportunities, while plant-based shell alternatives may create longer-term adjacency opportunities in Europe and North America. At the same time, gelatin-origin documentation, moisture sensitivity in powders, plant-based substitution pressure, and trade action affecting hard-empty capsule imports remain factors that suppliers and pharmaceutical buyers must monitor. The January 2026 U.S. trade action involving hard-empty capsules from Brazil, China, India, and Vietnam may further influence sourcing strategies for U.S.-focused buyers.
Unlock 360° insights for strategic decision making and investment planning:
For capsule manufacturers, documenting gelatin source, bloom strength, moisture range, and compatibility with filling equipment can help pharmaceutical customers streamline qualification. Drug makers can also benefit from selecting capsule sizes according to powder density and fill requirements at an early stage of product development. With prescription oral solid-dose demand remaining a key growth engine, the powder-filled hard gelatin capsules market is positioned for sustained expansion through 2036.
Countries chosen: USA, Germany, and France were selected because they combine the highest reported country growth rates with a strong pharmaceutical demand story, while ensuring European representation through Germany and France.
Explore More Related Studies Published by Fact.MR Research
Elastomeric Pump Cartridges Market
CPAP Humidifier Chambers Market
About Fact.MR
Fact.MR is a market research and consulting firm providing syndicated research, customized research, investment research, and market intelligence across a broad range of industries. Its research coverage includes food and beverage, healthcare, pharmaceuticals, biotechnology, consumer products, chemicals and materials, technology, industrial goods, and packaging.
Fact.MR provides market intelligence designed to help organizations understand market dynamics, emerging opportunities, competitive developments, and changing industry requirements.
Media Contact
Fact.MR
Email: [email protected]
Phone: +1 (628) 251-1583
Website: www.factmr.com
